Clinical Trials Directory

Trials / Completed

CompletedNCT01375309

Bifidobacterium Supplementation for Very Low Birth Weight Infants

Effect of Bifidobacterium Bifidum Supplementation on Morbidity of Very Low Birth Weight Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
246 (actual)
Sponsor
Tokyo Women's Medical University · Academic / Other
Sex
All
Age
48 Hours
Healthy volunteers
Not accepted

Summary

Probiotic supplementation to preterm infants have been reported to be beneficial in neonatal intensive care unit (NICU). Our pilot study also showed accelerated feeding in preterm infants who received Bifidobacterium bifidum early after birth. In order to evaluate these beneficial effects of Bifidobacterium bifidum, a prospective randomized control study is conducted. The hypothesis of the study is that Bifidobacterium bifidum supplementation to preterm infants improve enteral feeding and growth in very low birth weight infants.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBifidobacterium bifidum supplementationBifidobacterium bifidum supplementation wiht approximately 2.5\*10to9th bacteria per day
DIETARY_SUPPLEMENTPlacebo contains dextrin0.5 of dextrin

Timeline

Start date
2010-01-01
Primary completion
2011-06-01
Completion
2011-12-01
First posted
2011-06-17
Last updated
2012-03-30

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01375309. Inclusion in this directory is not an endorsement.